Attention Deficit Hyperactivity Disorder Medications and Sleep

Area of Science:

• Neuroscience
• Pharmacology
• Sleep Medicine

Background:

• Sleep disturbances are frequently reported in individuals with attention-deficit/hyperactivity disorder (ADHD).
• Initiating pharmacotherapy for ADHD can exacerbate or introduce sleep problems.
• Both stimulant and non-stimulant medications carry distinct sleep-related side effect profiles.

Purpose of the Study:

• To review the impact of ADHD pharmacotherapy on sleep patterns.
• To identify patient populations vulnerable to medication-induced sleep disturbances.
• To discuss potential management strategies for sleep issues in ADHD patients undergoing treatment.

Main Methods:

• Literature review of studies examining sleep effects of ADHD medications.
• Analysis of reported sleep-onset latency, insomnia, and daytime somnolence.
• Comparison of sleep-related adverse events across different medication classes and age groups.

Main Results:

• Stimulant medications for ADHD are frequently linked to delayed sleep onset and insomnia.
• Non-stimulant ADHD medications are more commonly associated with daytime sleepiness.
• Sleep disturbances vary in severity and duration, generally mild and improving over time.
• Preschoolers and adolescents exhibit higher vulnerability to medication-induced sleep disturbances.

Conclusions:

• Sleep problems are a common concern in ADHD pharmacotherapy, requiring careful monitoring.
• Age-dependent vulnerability necessitates tailored approaches to managing sleep side effects.
• Interventions include behavioral strategies, medication adjustments, and adjunctive sleep aids like melatonin.